Trial of Curcumin in Cutaneous T-cell Lymphoma Patients

NCT00969085 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Cutaneous T-cell Lymphoma

Interventions

DRUG: Curcumin (Turmeric)
BEHAVIORAL: Questionnaires
OTHER: Photos

Sponsor

M.D. Anderson Cancer Center